Immunova to Acquire AlphaTON Subsidiary Iox Therapeutics
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Bitcoin prices move due to demand shifts, liquidity, macro news, and mining dynamics. This concise guide highlights the most influential drivers traders watch.
23,432 articlesImmunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Six big forces could redefine how we borrow, buy, and refinance in 2026. This guide breaks down the economy, the hous...
A momentum-driven small-cap ETF with about $2.2 billion in assets again outpaced major benchmarks, drawing investor a...
Two retail giants, two very different paths to trillion-dollar status. This guide breaks down the case for Walmart an...
Carvana's 2025 earnings outlook centers on cash flow, balance-sheet repair, and smarter growth. This guide breaks dow...
Snap Inc has faced a severe share-price drop, but a mix of AR hardware progress, AI-enhanced ads, and international g...
Software stocks bounce Nvidia falters as investors rotate from AI-chip names to durable software franchises, signalin...
Paramount has emerged as the apparent victor in a months-long bidding war to buy Warner Bros. Discovery’s film and TV...
A multi-front conflict in the Middle East escalates, drawing in regional powers and global markets. Energy supplies, ...
U.S. stocks open on the back foot as Iran-related tensions flare, pushing futures lower and oil higher. Traders brace...
Occidental Petroleum uses $9.7B from the OxyChem sale to trim debt, boosting cash flow and dividends. Berkshire Hatha...
A notable fund recently reported a substantial exit in a popular beauty stock. We break down what this move could sig...